These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 591614)

  • 21. The metabolism of 35S-labelled antithyroid drugs in thyrotoxic, adenomatous, neoplastic and normal human thyroid.
    Lazarus JH; Marchant B; Alexander WD; Clark DH
    Clin Sci; 1973 Jun; 44(6):24P. PubMed ID: 4123392
    [No Abstract]   [Full Text] [Related]  

  • 22. [Metabolism of thioureylene antithyroid drugs--particularly with relationship between intrathyroidal metabolism of the drugs and the mechanisms of action (author's transl)].
    Nakashima T
    Rinsho Byori; 1982 Feb; 30(2):170-8. PubMed ID: 6177885
    [No Abstract]   [Full Text] [Related]  

  • 23. SIDE EFFECTS OF PTU AND MMI IN THE TREATMENT OF HYPERTHYROIDISM: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Yu W; Wu N; Li L; Wang J; OuYang H; Shen H
    Endocr Pract; 2020 Feb; 26(2):207-217. PubMed ID: 31652102
    [No Abstract]   [Full Text] [Related]  

  • 24. Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta-analysis.
    Agrawal M; Lewis S; Premawardhana L; Dayan CM; Taylor PN; Okosieme OE
    Clin Endocrinol (Oxf); 2022 Jun; 96(6):857-868. PubMed ID: 34845757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicological considerations for antithyroid drugs in children.
    Karras S; Tzotzas T; Krassas GE
    Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):399-410. PubMed ID: 21323607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism of 35S- and 14C-labeled propylthiouracil in a model in vitro system containing thyroid peroxidase.
    Taurog A; Dorris ML; Guziec FS; Uetrecht JP
    Endocrinology; 1989 Jun; 124(6):3030-7. PubMed ID: 2656249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic determination of carbimazole, methimazole and propylthiouracil in pharmaceuticals, animal feed and animal livers.
    Soledad García M; Albero MI; Sánchez-Pedreño C; Tobal L
    Analyst; 1995 Jan; 120(1):129-33. PubMed ID: 7710122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Excretion of antithyroid drugs in maternal milk].
    Johansen K; Kampmann JP; Hansen JM; Andersen AN; Helweg J
    Ugeskr Laeger; 1982 May; 144(22):1635-7. PubMed ID: 6182662
    [No Abstract]   [Full Text] [Related]  

  • 29. The pharmacokinetics of methimazole in pregnant patients after oral administration of carbimazole.
    Skellern GG; Knight BI; Otter M; Low CK; Alexander WD
    Br J Clin Pharmacol; 1980 Feb; 9(2):145-7. PubMed ID: 7356901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propylthiouracil versus methimazole in treatment of Graves' disease during pregnancy.
    Chattaway JM; Klepser TB
    Ann Pharmacother; 2007 Jun; 41(6):1018-22. PubMed ID: 17504839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic treatment of hyperthyroidism during pregnancy.
    Cassina M; Donà M; Di Gianantonio E; Clementi M
    Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):612-9. PubMed ID: 22511519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid conversion of carbimazole to methimazole in serum; evidence for an enzymatic mechanism.
    Nakashima T; Taurog A
    Clin Endocrinol (Oxf); 1979 Jun; 10(6):637-48. PubMed ID: 476986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of variations in acute and chronic iodine intake on the accumulation and metabolism of [35S]methimazole by the rat thyroid gland. Differences from [35S]propylthiouracil.
    Lang JC; Lees JF; Alexander WD; Ingbar SH
    Biochem Pharmacol; 1983 Jan; 32(2):241-7. PubMed ID: 6870954
    [No Abstract]   [Full Text] [Related]  

  • 34. Toxicities associated with 1-month treatment with propylthiouracil (PTU) and methimazole (MMI) in male rats.
    Nambiar PR; Palanisamy GS; Okerberg C; Wolford A; Walters K; Buckbinder L; Reagan WJ
    Toxicol Pathol; 2014 Aug; 42(6):970-83. PubMed ID: 24067673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Teratogen update: Antithyroid medications.
    Romeo AN; Običan SG
    Birth Defects Res; 2020 Sep; 112(15):1150-1170. PubMed ID: 32738035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reevaluation of the effects of methylmercaptoimidazole and propylthiouracil in patients with Graves' hyperthyroidism.
    Okamura K; Ikenoue H; Shiroozu A; Sato K; Yoshinari M; Fujishima M
    J Clin Endocrinol Metab; 1987 Oct; 65(4):719-23. PubMed ID: 3654917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacokinetics of methimazole after oral administration of carbimazole and methimazole, in hyperthyroid patients.
    Skellern GG; Knight BI; Low CK; Alexander WD; McLarty DG; Kalk WJ
    Br J Clin Pharmacol; 1980 Feb; 9(2):137-43. PubMed ID: 7356900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyrotoxicosis in pregnancy.
    Emerson CH
    Curr Ther Endocrinol Metab; 1994; 5():275-7. PubMed ID: 7704731
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative bioavailability of carbimazole and methimazole.
    Jansson R; Dahlberg PA; Lindström B
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):505-10. PubMed ID: 6642787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Side effects of anti-thyroid drugs and their impact on the choice of treatment for thyrotoxicosis in pregnancy.
    Taylor PN; Vaidya B
    Eur Thyroid J; 2012 Oct; 1(3):176-85. PubMed ID: 24783017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.